Thursday, June 2, 2016 8:18 AM
|
CCSVI in Multiple Sclerosis shared Canadian Neurovascular Health Society's post.
A missed opportunity to recommend interventions that could make a difference now in patients' lives: It's unfortunate that these researchers feel reductions in cerebral blood flow are useful only as a biomarker for pre-clinical Alzheimer's disease and not something that could be addressed through vascular interventions or dietary approaches to improve blood flow. http://link.springer.com/article/10.1007/s10571-015-0261-z
|